C3 and nephrotic syndrome: Baseline disease activity metrics (i.e. eGFR less than 60 ml/min/1.73 m2, existence of nephrotic syndrome, and levels of anti-dsDNA antibody and serum C3 levels) were not associated with renal function decline (Table 4).